Casandra
Casandra Test Code NG47018Version 1 (DRAFT)
Performing Lab
Full Comprehensive Cancer Panel (Germline)
Clinical Use
Order TestUse
This germline next‑generation sequencing panel assesses hereditary cancer predisposition by analyzing a comprehensive set of 127 genes. It is performed by Fulgent Genetics via send‑out testing, informing risk assessment and potential familial implications.
Special Instructions
Testing is performed by Fulgent Genetics; test is a send‑out to Fulgent Genomics.
Limitations
Not provided.
Test Details
New York Approved
Methodology
NGS (Targeted)
Biomarkers
2 components
DNA Sequencing • TargetedRNA Sequencing • Targeted
Result Turnaround Time
null-23 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
two x 4 mL
Minimum Volume
Not provided
Container
EDTA tubes
Storage Instructions
Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.